Association of immune response parameters with virological response in hepatitis C virus patients treated with pegylated consensus interferon
{{output}}
Background: A new, potent, long lasting recombinant interferon variant (pegylated consensus interferon, PEGCIFN) was expressed by Escherichia coli. The aim of this study was to test safety and antiviral activity of the new type o... ...
